Inventor

Chaim Gilon

Inventor

Jerusalem, IL

Overview

24→

Patents

1993–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes25%

C07KPeptides21%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%

Y02PClimate change mitigation technologies in the production or processing of goods11%

C07CAcyclic or carbocyclic compounds10%

C07DHeterocyclic compounds8%

A23KFodder2%

G01RMeasuring electric variables2%

A01KAnimal husbandry1%

C12NMicroorganisms or enzymes1%

PatentTitleYear

10,793,614Antagonists of fish reproduction2020 10,662,225Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88)2020 10,155,790Antagonists of neurokinin B in fish reproduction2018 9,725,484'Methods and compositions for the treatment of bone remodeling disorders'2017 9,555,086'Compositions and methods for inducing an immune response'2017 8,658,603'Compositions and methods for inducing an immune response'2014 8,198,218'Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads'2012 7,084,244'Conformationally constrained backbone cyclized peptide analogs'2006 RE038761'Styryl compounds which inhibit EGF receptor protein tyrosine kinase'2005 6,664,368'Inhibition of nuclear import by backbone cyclic peptide analogs'2003 6,407,059'Conformationally constrained backbone cyclized peptide analogs'2002 6,265,375'Conformationally constrained backbone cyclized peptide analogs'2001 6,117,974'Libraries of backbone-cyclized peptidomimetics'2000 5,990,277'Semipeptoid farnesyl protein transferase inhibitors and analogs thereof'1999 5,883,293'Conformationally constrained backbone cyclized peptide analogs'1999 5,874,529'Conformationally constrained backbone cyclized peptide analogs'1999 5,811,392'Conformationally constrained backbone cyclized peptide analogs'1998 5,770,687'Comformationally constrained backbone cyclized somatostatin analogs'1998 5,723,575'Process for the preparation of backbone cyclic peptides'1998 5,677,329'Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase'1997 5,656,655'Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase'1997 5,302,606'Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase'1994 5,217,999'Styryl compounds which inhibit EGF receptor protein tyrosine kinase'1993 5,196,446'Certain indole compounds which inhibit EGF receptor tyrosine kinase'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2017Patents assigned to YISSUM RES DEV CO (14)· patent assignee history

1993–2020Based in Jerusalem, IL· patent location history

1994–1997Patents assigned to RHONE POULENC RORER PHARMA (2)· patent assignee history

1998–2003Patents assigned to PEPTOR LTD (8)· patent assignee history

2012–2014Patents assigned to GILON CHAIM (2)· patent assignee history

2018–2020Patents assigned to YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
YISSUM RES DEV CO	14	1993–2017
PEPTOR LTD	8	1998–2003
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD	3	2018–2020
GILON CHAIMself	2	2012–2014
RHONE POULENC RORER PHARMA	2	1994–1997

Locations

Location	Patents	Span
Jerusalem, IL	24	1993–2020